Pressearchiv - Pressemitteilungen Archiv: September 2009
Large North American sports broadcaster expands media network (30.09.2009)
IBUg 2009 ends succesfully (30.09.2009)
Hornbach posts further growth (30.09.2009)
Aker Solutions awarded FEED contract for upgrading of Gullfaks A drilling facilities (30.09.2009)
Mistakes that one normally makes with the website search engine submission (30.09.2009)
Directorate Change (30.09.2009)
UCB announces an increase in the amount of the issuance of its convertible bond offering to up to EU (30.09.2009)
Notification of Major Interests in Shares (30.09.2009)
Public broadcaster in Europe expands media transport network with Net Insight (30.09.2009)
Net Asset Value(s) (30.09.2009)
Change in the number of shares and votes in Investment AB Kinnevik (30.09.2009)
Half-yearly report (30.09.2009)
New CellaVision® DM1200 analyzer approved for sales in Canada (30.09.2009)
Half-yearly report (30.09.2009)
Consolidated Abaddon Begins Exploration on Raleigh Lake Lithium Project (30.09.2009)
Vacon supplies AC drives to Kama paper mill in Russia (30.09.2009)
Change in numbers of shares in BioPhausia AB (publ) (30.09.2009)
APPROVAL OF SHARE SUBSCRIPTIONS WITH STOCK OPTIONS (30.09.2009)
The Federal Arbitrazh (Business) Court of the West Siberia District Adjourns Hearing of Telenor's Ap (30.09.2009)
Teuvo Salminen to join CapMan as an Advisor (30.09.2009)
AMG announces change to Management Board (30.09.2009)
Change in the number of votes in Tele2 (30.09.2009)
Total voting rights (30.09.2009)
Final Results (30.09.2009)
RIE: Rieber sells Sopps brand (30.09.2009)
Half-yearly report (30.09.2009)
Glenlivet discovery - successful side track appraisal well (30.09.2009)
Half-yearly Results (30.09.2009)
CHANGE IN PÿYRY'S TOP MANAGEMENT (30.09.2009)
Pharming receives commitment for conversion of 70% of outstanding bonds (30.09.2009)
UCB launches an offer of up to EUR 350 million convertible bonds, due 2015 (30.09.2009)
Strategic acquisition of Duo-Med in Belgium (30.09.2009)
Crucell Strengthens its Vaccine Sales in the UK with a Dedicated Marketing and Sales Organization (30.09.2009)
Year-end and fourth quarter report for the 2008/2009 financial year - Statement of strength from Kap (30.09.2009)
Elcoteq Chooses a New Strategic Partner in the Equity Process and Ends Negotiations with Kaifa (30.09.2009)
Two-year Phase III study shows Novartis oral MS therapy FTY720 significantly reduces relapses and di (30.09.2009)
Half-yearly report (30.09.2009)
Notice of EGM (29.09.2009)
Statement re Possible Offer (29.09.2009)
Net Asset Value(s) (29.09.2009)
Wählen Sie einen Monat, der angezeigt werden soll:
